BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan
· Delayed Price · Currency is TWD 29.10
+0.10 (0.34%)
Apr 29, 2026, 1:19 PM CST
BioLASCO Taiwan Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 262.66 | 292.5 | 264.72 | 235.91 | 227.58 | Upgrade
|
| Revenue Growth (YoY) | -10.20% | 10.49% | 12.21% | 3.66% | -23.86% | Upgrade
|
| Cost of Revenue | 157.89 | 177.74 | 160.37 | 131.43 | 122.47 | Upgrade
|
| Gross Profit | 104.78 | 114.76 | 104.35 | 104.49 | 105.11 | Upgrade
|
| Selling, General & Admin | 56.66 | 59.06 | 53.54 | 55.22 | 51.18 | Upgrade
|
| Operating Expenses | 56.73 | 59.02 | 53.59 | 55.22 | 51.21 | Upgrade
|
| Operating Income | 48.04 | 55.74 | 50.76 | 49.27 | 53.89 | Upgrade
|
| Interest Expense | -2.03 | -1.76 | -1.3 | -1.09 | -0.88 | Upgrade
|
| Interest & Investment Income | 1.61 | 2.41 | 1.83 | 0.73 | 0.47 | Upgrade
|
| Earnings From Equity Investments | 0.81 | 1.72 | 8.72 | 4.68 | 2.72 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.18 | 0.31 | -0.52 | 0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.13 | 0.28 | 1.66 | 0.05 | 0.04 | Upgrade
|
| EBT Excluding Unusual Items | 49.56 | 58.56 | 61.99 | 53.14 | 56.44 | Upgrade
|
| Other Unusual Items | - | -3.64 | - | - | - | Upgrade
|
| Pretax Income | 49.56 | 54.92 | 61.99 | 53.14 | 56.44 | Upgrade
|
| Income Tax Expense | 7.14 | 10.89 | 12.25 | 10.83 | 11.29 | Upgrade
|
| Earnings From Continuing Operations | 42.43 | 44.03 | 49.74 | 42.31 | 45.15 | Upgrade
|
| Net Income | 42.43 | 44.03 | 49.74 | 42.31 | 45.15 | Upgrade
|
| Net Income to Common | 42.43 | 44.03 | 49.74 | 42.31 | 45.15 | Upgrade
|
| Net Income Growth | -3.63% | -11.49% | 17.57% | -6.29% | -28.10% | Upgrade
|
| Shares Outstanding (Basic) | 26 | 26 | 26 | 26 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 26 | 26 | 26 | 26 | Upgrade
|
| Shares Change (YoY) | 0.24% | -0.02% | -0.00% | -0.02% | -0.03% | Upgrade
|
| EPS (Basic) | 1.65 | 1.72 | 1.94 | 1.65 | 1.76 | Upgrade
|
| EPS (Diluted) | 1.65 | 1.72 | 1.94 | 1.65 | 1.76 | Upgrade
|
| EPS Growth | -4.02% | -11.39% | 17.58% | -6.25% | -28.16% | Upgrade
|
| Free Cash Flow | 27.06 | 1.04 | 27.83 | 40.88 | 66.62 | Upgrade
|
| Free Cash Flow Per Share | 1.05 | 0.04 | 1.08 | 1.59 | 2.60 | Upgrade
|
| Dividend Per Share | - | 1.500 | 1.650 | 1.500 | 1.600 | Upgrade
|
| Dividend Growth | - | -9.09% | 10.00% | -6.25% | -20.00% | Upgrade
|
| Gross Margin | 39.89% | 39.23% | 39.42% | 44.29% | 46.18% | Upgrade
|
| Operating Margin | 18.29% | 19.06% | 19.18% | 20.88% | 23.68% | Upgrade
|
| Profit Margin | 16.15% | 15.05% | 18.79% | 17.94% | 19.84% | Upgrade
|
| Free Cash Flow Margin | 10.30% | 0.35% | 10.51% | 17.33% | 29.27% | Upgrade
|
| EBITDA | 59.58 | 64.45 | 58.96 | 56.91 | 62.07 | Upgrade
|
| EBITDA Margin | 22.68% | 22.04% | 22.27% | 24.12% | 27.27% | Upgrade
|
| D&A For EBITDA | 11.53 | 8.71 | 8.2 | 7.64 | 8.18 | Upgrade
|
| EBIT | 48.04 | 55.74 | 50.76 | 49.27 | 53.89 | Upgrade
|
| EBIT Margin | 18.29% | 19.06% | 19.18% | 20.88% | 23.68% | Upgrade
|
| Effective Tax Rate | 14.40% | 19.83% | 19.76% | 20.38% | 20.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.